Koers Kazia Therapeutics Australian S.E.
Aandelen
KZA
AU000000KZA9
Biotechnologie & Medisch Onderzoek
Omzet 2022 | 10K 6,5K 6,07K | Omzet 2023 | 555 360,84 336,87 | Marktkapitalisatie | 39,72 mln. 25,82 mln. 24,11 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -24 mln. -15,6 mln. -14,57 mln. | Nettowinst (verlies) 2023 | -20 mln. -13 mln. -12,14 mln. | EV/omzet 2022 | 7.714 x |
Nettoliquiditeiten 2022 | 7,36 mln. 4,79 mln. 4,47 mln. | Nettoliquiditeiten 2023 | 3,44 mln. 2,24 mln. 2,09 mln. | EV/omzet 2023 | 65.355 x |
K/w-verhouding 2022 |
-3,27
x | K/w-verhouding 2023 |
-1,55
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 45,6% |
Recentste transcriptie over Kazia Therapeutics
Vaira. 1 jan. | Kapi. | |
---|---|---|
+1,34% | 42,86 mld. | |
+11,93% | 42,74 mld. | |
+45,15% | 41,36 mld. | |
-8,83% | 27,68 mld. | |
+7,28% | 25,15 mld. | |
-23,61% | 18,63 mld. | |
+29,52% | 12,37 mld. | |
-2,21% | 11,92 mld. | |
+7,34% | 11,21 mld. |